Recorded Webinar from Nov 9, 2017
Assessing the immunogenicity of biopharmaceuticals
Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing.
By listening to this webinar, you will learn:
Application Scientist, Gyros Protein Technologies AB
Manager Biopharma Solutions, Euro Diagnostica AB
If you have problems to view the webinar please contact email@example.com